Peter Kamper

981 total citations
41 papers, 532 citations indexed

About

Peter Kamper is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Kamper has authored 41 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pathology and Forensic Medicine, 20 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Kamper's work include Lymphoma Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (13 papers) and Viral-associated cancers and disorders (6 papers). Peter Kamper is often cited by papers focused on Lymphoma Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (13 papers) and Viral-associated cancers and disorders (6 papers). Peter Kamper collaborates with scholars based in Denmark, Sweden and Norway. Peter Kamper's co-authors include Francesco d’Amore, Stephen Hamilton‐Dutoit, Knud Bendix, Bent Honoré, Jens Randel Nyengaard, Maja Ludvigsen, Maja Dam Andersen, Michael Roost Clausen, Michael Møller and Gabriel A. Rabinovich and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Peter Kamper

34 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kamper Denmark 11 346 267 189 83 68 41 532
Michio Sawada Japan 15 302 0.9× 207 0.8× 152 0.8× 78 0.9× 42 0.6× 37 577
Sverker Hasselblom Sweden 14 320 0.9× 209 0.8× 145 0.8× 79 1.0× 44 0.6× 25 494
Monika Długosz‐Danecka Poland 13 297 0.9× 226 0.8× 68 0.4× 81 1.0× 58 0.9× 44 485
Barbara Jezeršek Novaković Slovenia 12 184 0.5× 164 0.6× 98 0.5× 40 0.5× 46 0.7× 43 400
Mei Dong China 14 442 1.3× 379 1.4× 177 0.9× 50 0.6× 79 1.2× 49 775
Qingyuan Zhang China 10 226 0.7× 245 0.9× 87 0.5× 101 1.2× 70 1.0× 48 460
Olav Erich Yri Norway 10 202 0.6× 218 0.8× 119 0.6× 31 0.4× 112 1.6× 22 484
Ken Ohmachi Japan 13 403 1.2× 342 1.3× 91 0.5× 107 1.3× 46 0.7× 46 599
Jens Kuhlmann Germany 9 324 0.9× 220 0.8× 108 0.6× 26 0.3× 100 1.5× 13 585
Lin Nong China 12 218 0.6× 197 0.7× 96 0.5× 29 0.3× 19 0.3× 62 424

Countries citing papers authored by Peter Kamper

Since Specialization
Citations

This map shows the geographic impact of Peter Kamper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kamper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kamper more than expected).

Fields of papers citing papers by Peter Kamper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kamper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kamper. The network helps show where Peter Kamper may publish in the future.

Co-authorship network of co-authors of Peter Kamper

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kamper. A scholar is included among the top collaborators of Peter Kamper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kamper. Peter Kamper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bæch, Joachim, Marianne Tang Severinsen, Lasse Hjort Jakobsen, et al.. (2024). Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study. British Journal of Haematology. 205(2). 542–551.
4.
Andersen, Maja Dam, Katharina Wolter, Stephen Hamilton‐Dutoit, et al.. (2024). Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity. Leukemia & lymphoma. 66(4). 656–667.
5.
Eriksson, Frank, Charlotte Glinge, Tarec Christoffer El‐Galaly, et al.. (2024). Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study. British Journal of Haematology. 205(4). 1374–1382. 1 indexed citations
6.
Groen, Ruben A. L. de, Peter Kamper, P Rasmussen, et al.. (2024). The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa. International Journal of Molecular Sciences. 25(6). 3094–3094.
7.
Eloranta, Sandra, Marianne Tang Severinsen, Knut B. Smeland, et al.. (2024). Machine Learning–Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma. JCO Clinical Cancer Informatics. 8(8). e2300255–e2300255. 6 indexed citations
8.
Andersen, Maja Dam, Katharina Wolter, Lars Christian Gormsen, et al.. (2024). Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal Involvement. European Journal Of Haematology. 114(1). 173–185. 1 indexed citations
9.
Bæch, Joachim, Signe Riddersholm, Lars Køber, et al.. (2024). Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register‐Based Cohort Study. European Journal Of Haematology. 114(2). 343–352. 1 indexed citations
10.
Andersen, Maja Dam, Stephen Hamilton‐Dutoit, Ilse Christiansen, et al.. (2022). Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma – A study from the Danish Lymphoma Registry. British Journal of Haematology. 198(1). 50–61. 8 indexed citations
11.
Jakobsen, Lasse Hjort, Sandra Eloranta, Kristian Kragholm, et al.. (2021). Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study. Journal of Clinical Oncology. 39(31). 3463–3472. 14 indexed citations
12.
Mikkelsen, Lauge Hjorth, Peter Kamper, P Rasmussen, et al.. (2020). Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017. British Journal of Ophthalmology. 105(7). 914–920. 16 indexed citations
13.
Gormsen, Lars Christian, Peter Kamper, Cecilia Wassberg, et al.. (2019). Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first‐line chemotherapy. British Journal of Haematology. 186(3). 431–439. 4 indexed citations
14.
Fosså, Alexander, Helen Goergen, Peter Kamper, et al.. (2018). B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG). Kölner Universitäts PublikationsServer (Universität zu Köln).
15.
Hollander, Peter, Peter Kamper, Karin E. Smedby, et al.. (2016). High Expression Of Programmed Cell Death Receptor 1 In The Tumor Microenvironment Is Associated With Inferior Event Free Survival In Classical Hodgkin Lymphoma. Haematologica. 101. 1–2. 4 indexed citations
16.
Gormsen, Lars Christian, et al.. (2016). The Importance Of Bone Marrow 18F-Fdg Uptake And Focal Skeletal Lesions On Survival In Patients With Newly Diagnosed Hodgkin Lymphoma. Haematologica. 101. 42–42. 3 indexed citations
17.
18.
El‐Galaly, Tarec Christoffer, Martin Hutchings, Karen Juul Mylam, et al.. (2013). Impact of18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement. Leukemia & lymphoma. 55(10). 2349–2355. 17 indexed citations
19.
Kamper, Peter, Knud Bendix, Stephen Hamilton‐Dutoit, et al.. (2010). Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica. 96(2). 269–276. 159 indexed citations
20.
Kamper, Peter, Eigil Kjeldsen, Niels Clausen, et al.. (2005). Epstein‐Barr virus‐associated familial Hodgkin lymphoma: paediatric onset in three of five siblings. British Journal of Haematology. 129(5). 615–617. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michio Sawada Breakdown of academic impact, for papers by Sverker Hasselblom Breakdown of academic impact, for papers by Monika Długosz‐Danecka Breakdown of academic impact, for papers by Barbara Jezeršek Novaković Breakdown of academic impact, for papers by Mei Dong Breakdown of academic impact, for papers by Qingyuan Zhang Breakdown of academic impact, for papers by Olav Erich Yri Breakdown of academic impact, for papers by Ken Ohmachi Breakdown of academic impact, for papers by Jens Kuhlmann Breakdown of academic impact, for papers by Lin Nong
Rankless by CCL
2026